Diaceutics PLC
DXRX.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£1,908 | -£1,746 | £724 | £561 |
| Dep. & Amort. | £4,627 | £4,773 | £3,008 | £1,799 |
| Deferred Tax | £0 | £0 | -£6,965 | -£5,684 |
| Stock-Based Comp. | £1,020 | £445 | £621 | £428 |
| Change in WC | -£1,302 | -£1,540 | -£328 | -£1,658 |
| Other Non-Cash | -£1,786 | -£621 | £8,036 | £5,124 |
| Operating Cash Flow | £651 | £1,311 | £5,148 | £570 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£100 | -£125 | -£4,870 | -£5,601 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | -£3,931 | -£4,084 | £0 | £0 |
| Investing Cash Flow | -£4,031 | -£4,209 | -£4,870 | -£5,601 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -£199 | -£179 | -£163 | -£56 |
| Stock Issued | £136 | £0 | £129 | £0 |
| Stock Repurch. | £0 | -£49 | -£98 | -£165 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£1 | -£11 | £0 | -£49 |
| Financing Cash Flow | -£64 | -£239 | -£132 | -£270 |
| Forex Effect | -£479 | -£37 | £20 | -£279 |
| Net Chg. in Cash | -£3,923 | -£3,174 | £166 | -£5,580 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £16,667 | £19,841 | £19,675 | £25,255 |
| End Cash | £12,744 | £16,667 | £19,841 | £19,675 |
| Free Cash Flow | -£3,981 | -£3,544 | £278 | -£5,031 |